RankingsPricing
  1. US-listed companies
  2. ABBOTT LABORATORIES
  3. Raw

ABBOTT LABORATORIESABT

Market cap
$223B
P/E ratio
SummaryFinancials
Back to summarized table
Dec 31,
2010		Dec 31,
2011		Dec 31,
2012		Dec 31,
2013		Dec 31,
2014		Dec 31,
2015		Dec 31,
2016		Dec 31,
2017		Dec 31,
2018		Dec 31,
2019		Dec 31,
2020		Dec 31,
2021		Dec 31,
2022		Dec 31,
2023		Dec 31,
2024
Net earnings4,626--2,5762,2844,4231,4004772,3683,6874,4957,0716,9335,72313,402
Depreciation1,2071,3951,3649289188718031,0461,1001,0781,1951,4911,2541,2771,340
Amortization of intangible assets1,4171,6491,4207916306015501,9752,1781,9362,1322,0472,0131,9661,878
Share-based compensation387383433262246292310406477519546640685644673
Investing and financing losses, net-126-142-356-4-6918-86-47-126-184-425-55-215-126-482
Trade receivables395670-3611319517117720719027592438368356691
Inventories-14013041715429725798-2495145934934561,41323258
Prepaid expenses and other assets-553-41335-131-30-57-113-109-2313862731275542796
Trade accounts payable and other liabilities-1,790-134-436-225-742-6526157472201,7661,288420-760356
Income taxes-212-1,402-1,309-665197957-6991,149-214-545-614-908-383-585-8,028
Net Cash From Operating Activities---3,3243,6752,9663,2035,5706,3006,1367,90110,5339,5817,2618,558
Acquisitions of property and equipment1,0151,4921,7951,1451,0771,1101,1211,1351,3941,6382,1771,8851,7772,2022,207
Acquisitions of businesses and technologies, net of cash acquired---------17042187-877-
Proceeds from business dispositions-----230256,04248485813448401
Purchases of investment securities------------185159169
Proceeds from Sale of Other Investments------------1524328
Other18-16-3-21-75-52-42-35-48-27-19-26-22-22-9
Net Cash From (Used in) Investing Activities-12,188---3,929-202406-248-9,618-1,356-1,815-2,215-2,008-1,740-3,133-2,338
Proceeds from (Repayments of) Short-Term Debt-204-1,9657842,0861,343-1,281-1,767-1,034-26-2-2044721-100
Proceeds from Long-Term Debt and Debt Maturing in More than Three Months------------72223
Repayments of long-term debt and debt with maturities over 3 months------------7532,498660
Purchases of common shares867772,3641,6052,1952,2375221172387184032,2993,7951,2271,295
Proceeds from stock options exercised3289691,850395429314248350271298245255167167264
Dividends paid------1,5391,8491,9742,2702,5603,2023,3093,5563,836
Net Cash From (Used in) Financing Activities-1,088---6,696-2,742-2,23611,147-5,281-10,391-4,289-2,779-5,494-7,636-7,091-5,404
Effect of exchange rate changes on cash and cash equivalents---------116-1671-70-122-23-96
Net Increase (Decrease) in Cash and Cash Equivalents---------5,563162,9782,96183-2,986720
Income taxes paid-------5707409309701,9411,8641,4751,723
Interest paid-------917845677549544563662604